Literature DB >> 21590138

Human achaete-scute homolog-1 is highly expressed in a subset of neuroendocrine tumors.

H Chen1, R Udelsman, M Zeiger, D Ball.   

Abstract

Human achaete-scute homolog-1 (hASH1) is critical for establishing the neuroendocrine (NE) phenotype of small cell lung cancer. To define its role in other neoplasms, we analyzed 33 tumors for hASH1 by Northern blotting. Significant levels of hASH1 mRNA were detected in 4 pheochromocytomas, 2 medullary thyroid cancers, and 1 thymic carcinoid. hASH1 transcripts were undetectable in 8 parathyroid lesions, 6 gastrinomas, 4 insulinomas, and 7 thyroid neoplasms, as well as in normal thyroid, adrenal, or pancreas tissue. Therefore, hASH1 mRNA is highly abundant in a subset of human tumors and may play a role in dictating their NE phenotype.

Entities:  

Year:  1997        PMID: 21590138     DOI: 10.3892/or.4.4.775

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Expression of the active Notch1 decreases MTC tumor growth in vivo.

Authors:  Renata Jaskula-Sztul; Pongthep Pisarnturakit; Michael Landowski; Herbert Chen; Muthusamy Kunnimalaiyaan
Journal:  J Surg Res       Date:  2011-04-13       Impact factor: 2.192

2.  KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy.

Authors:  Guojun Chen; Renata Jaskula-Sztul; April Harrison; Ajitha Dammalapati; Wenjin Xu; Yiqiang Cheng; Herbert Chen; Shaoqin Gong
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

3.  MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.

Authors:  Jocelyn F Burke; Logan Schlosser; April D Harrison; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2013-07-31       Impact factor: 5.344

4.  AB3-Loaded and Tumor-Targeted Unimolecular Micelles for Medullary Thyroid Cancer Treatment.

Authors:  Renata Jaskula-Sztul; Guojun Chen; Ajitha Dammalapati; April Harrison; Weiping Tang; Shaoqin Gong; Herbert Chen
Journal:  J Mater Chem B       Date:  2016-12-02       Impact factor: 6.331

5.  Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.

Authors:  Renata Jaskula-Sztul; Wenjin Xu; Guojun Chen; April Harrison; Ajitha Dammalapati; Renu Nair; Yiqiang Cheng; Shaoqin Gong; Herbert Chen
Journal:  Biomaterials       Date:  2016-03-08       Impact factor: 12.479

6.  Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy.

Authors:  Wenjin Xu; Jocelyn F Burke; Srikanth Pilla; Herbert Chen; Renata Jaskula-Sztul; Shaoqin Gong
Journal:  Nanoscale       Date:  2013-10-21       Impact factor: 7.790

7.  Leflunomide suppresses growth in human medullary thyroid cancer cells.

Authors:  Amal Alhefdhi; Jocelyn F Burke; Aaron Redlich; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  J Surg Res       Date:  2013-06-19       Impact factor: 2.192

8.  Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.

Authors:  Sara Tesfazghi; Jacob Eide; Ajitha Dammalapati; Colin Korlesky; Thomas P Wyche; Tim S Bugni; Herbert Chen; Renata Jaskula-Sztul
Journal:  Cancer Med       Date:  2013-09-17       Impact factor: 4.452

9.  Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo.

Authors:  T P Wyche; A Dammalapati; H Cho; A D Harrison; G S Kwon; H Chen; T S Bugni; R Jaskula-Sztul
Journal:  Cancer Gene Ther       Date:  2014-11-21       Impact factor: 5.987

10.  Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.

Authors:  Muthusamy Kunnimalaiyaan; Megan R Haymart; Herbert Chen
Journal:  Transl Oncogenomics       Date:  2007-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.